Cargando…

NK cells and solid tumors: therapeutic potential and persisting obstacles

Natural killer (NK) cells, which are innate lymphocytes endowed with potent cytotoxic activity, have recently attracted attention as potential anticancer therapeutics. While NK cells mediate encouraging responses in patients with leukemia, the therapeutic effects of NK cell infusion in patients with...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tong, Le, Jiménez-Cortegana, Carlos, Tay, Apple H.M., Wickström, Stina, Galluzzi, Lorenzo, Lundqvist, Andreas
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9623927/ https://www.ncbi.nlm.nih.gov/pubmed/36319998 http://dx.doi.org/10.1186/s12943-022-01672-z

Ejemplares similares

Targeting of Nrf2 improves antitumoral responses by human NK cells, TIL and CAR T cells during oxidative stress
por: Renken, Stefanie, et al.
Publicado: (2022)

Strategies to Augment Natural Killer (NK) Cell Activity against Solid Tumors
por: Chen, Ziqing, et al.
Publicado: (2019)

The Tumor Microenvironment—A Metabolic Obstacle to NK Cells’ Activity
por: Domagala, Joanna, et al.
Publicado: (2020)

Lactate from the tumor microenvironment - A key obstacle in NK cell-based immunotherapies
por: Jedlička, Marek, et al.
Publicado: (2022)

The Biological Role and Therapeutic Potential of NK Cells in Hematological and Solid Tumors
por: Velichinskii, Rodion A., et al.
Publicado: (2021)

Regulatory T Cells Inhibit T Cell Activity by Downregulating CD137 Ligand via CD137 Trogocytosis
por: Luu, Khang, et al.
Publicado: (2021)

Calreticulin arms NK cells against leukemia
por: Fucikova, Jitka, et al.
Publicado: (2019)

Obstacles and Coping Strategies of CAR-T Cell Immunotherapy in Solid Tumors
por: Miao, Lele, et al.
Publicado: (2021)

Surmounting the obstacles that impede effective CAR T cell trafficking to solid tumors
por: Donnadieu, Emmanuel, et al.
Publicado: (2020)

Editorial: NK-Myeloid Cell Interactions in the Tumor Microenvironment: Implications for Cancer Immunotherapy
por: Wennerberg, Erik, et al.
Publicado: (2021)

NK cells beat T cells at early breast cancer control
por: Buque, Aitziber, et al.
Publicado: (2020)

CAR-NK Cells in the Treatment of Solid Tumors
por: Wrona, Ewa, et al.
Publicado: (2021)

CD25(bright) NK cells display superior function and metabolic activity under regulatory T cell-mediated suppression
por: Chen, Ziqing, et al.
Publicado: (2023)

Influence of the Tumor Microenvironment on NK Cell Function in Solid Tumors
por: Melaiu, Ombretta, et al.
Publicado: (2020)

Engineered NK Cells Against Cancer and Their Potential Applications Beyond
por: Karvouni, Maria, et al.
Publicado: (2022)

Human NK Cells: From Surface Receptors to the Therapy of Leukemias and Solid Tumors
por: Moretta, Lorenzo, et al.
Publicado: (2014)

Major biological obstacles for persistent cell-based regeneration of articular cartilage
por: Steinert, Andre F, et al.
Publicado: (2007)

Nanoparticle-Based Therapeutics to Overcome Obstacles in the Tumor Microenvironment of Hepatocellular Carcinoma
por: Lu, Yuanfei, et al.
Publicado: (2022)

Challenges and Obstacles in Applying Therapeutical Indications Formulated in Molecular Tumor Boards
por: Crimini, Edoardo, et al.
Publicado: (2022)

NK Cells, Tumor Cell Transition, and Tumor Progression in Solid Malignancies: New Hints for NK-Based Immunotherapy?
por: Cantoni, Claudia, et al.
Publicado: (2016)

Wishes and obstacles to having children – Results from the nationwide Healthy Finland survey
por: Lehtoranta, L, et al.
Publicado: (2023)

Tumor MHC class I expression alters cancer-associated myelopoiesis driven by host NK cells
por: Neo, Shi Yong, et al.
Publicado: (2022)

Chimeric Antigen Receptor T Cell Therapy for Solid Tumors: Current Status, Obstacles and Future Strategies
por: Heyman, Benjamin, et al.
Publicado: (2019)

Blood–brain barrier: a real obstacle for therapeutics
por: Shiekh, Farooq A
Publicado: (2012)

Therapeutic payload delivery to the myocardium: Evolving strategies and obstacles
por: Shazly, Tarek, et al.
Publicado: (2022)

Targeting MET Amplification: Opportunities and Obstacles in Therapeutic Approaches
por: Kumaki, Yuichi, et al.
Publicado: (2023)

Travelling along a road with obstacles: Experiences of managing life to feel well while living with migraine
por: Rutberg, Stina, et al.
Publicado: (2013)

Overcoming the Obstacle of Polymer–Polymer Resistances in Double Layer Solid Polymer Electrolytes
por: Sångeland, Christofer, et al.
Publicado: (2021)

Editorial: The regulatory immune system as a target to improve adjuvants and novel vaccines
por: Jiménez-Cortegana, Carlos, et al.
Publicado: (2023)

Re-discovering NK cell allo-reactivity in the therapy of solid tumors
por: Castagna, Luca, et al.
Publicado: (2016)

Inhibition of NK Reactivity Against Solid Tumors by Platelet-Derived RANKL
por: Clar, Kim L., et al.
Publicado: (2019)

Challenges and Recent Advances in NK Cell-Targeted Immunotherapies in Solid Tumors
por: Lian, Guangyu, et al.
Publicado: (2021)

Murine models to study human NK cells in human solid tumors
por: Parodi, Monica, et al.
Publicado: (2023)

Interaction Between MDSC and NK Cells in Solid and Hematological Malignancies: Impact on HSCT
por: Tumino, Nicola, et al.
Publicado: (2021)

Scattering by obstacles
por: Ramm, A G
Publicado: (1986)

Overcoming Obstacles
por: Braile, Domingo M.
Publicado: (2015)

Cytokine engineered NK-92 therapy to improve persistence and anti-tumor activity
por: Shin, Hyun Young, et al.
Publicado: (2023)

Overview obstacle maps for obstacle‐aware navigation of autonomous drones
por: Pestana, Jesús, et al.
Publicado: (2019)

Design and Implementation of NK Cell-Based Immunotherapy to Overcome the Solid Tumor Microenvironment
por: Navin, Ishwar, et al.
Publicado: (2020)

Persistent high fertility in Uganda: young people recount obstacles and enabling factors to use of contraceptives
por: Nalwadda, Gorrette, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_us488qsjo5e60cst8frsrthd5k